Publication | Closed Access

The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3–5

Urate-lowering EfficacyUrologyRenal DiseaseRenal FunctionKidney FailureChronic Kidney DiseaseRenal InflammationDiuretic ResistanceMedicineNephrologyChinese Patients